Judge OKs $42M Stent IP Verdict, Discards Willfulness Finding <https://www.law360.com/delaware/articles/1844839?nl_pk=8f2e5a76-bb66-462b-a05a-b234142584d6&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2024-06-07&read_main=1&nlsidx=0&nlaidx=2> By Adam Lidgett A Delaware federal judge has said Boston Scientific was not entitled to a new trial in a case where it was told to pay $42 million for stent systems patent infringement, but threw out a finding of willful infringement. Memorandum attached | Read full article » <https://www.law360.com/delaware/articles/1844839?nl_pk=8f2e5a76-bb66-462b-a05a-b234142584d6&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2024-06-07&read_more=1&nlsidx=0&nlaidx=2> | Save to favorites » <https://www.law360.com/delaware/articles/1844839?nl_pk=8f2e5a76-bb66-462b-a05a-b234142584d6&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2024-06-07&read_later=1&nlsidx=0&nlaidx=2>